Status:
RECRUITING
Persuasive Health Communication Intervention for HIV/HCV
Lead Sponsor:
Icahn School of Medicine at Mount Sinai
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Human Immunodeficiency Virus (HIV)
Hepatitis C (HCV)
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
A major impediment to emergency department (ED)-based HIV/HCV screening success is that often ED patients at risk for, or later diagnosed with, HIV and HCV decline testing. In this R01 project, the re...
Detailed Description
As part of routine practice at Mount Sinai Health System EDs, the ED Nurses initiate HIV/HCV screening for all patients able to provide consent. ED patients eligible for recruitment into the RCT porti...
Eligibility Criteria
Inclusion
- ≥18 years-old
- Speak English or Spanish, and able to provide informed consent for study participation
- Not HIV AND HCV infected/Antibody+ (per EHR review and patient report)
- Not already participating in a HIV or HCV study (e.g., HIV PrEP, HIV vaccine)
- Not tested for HIV OR HCV within the past 12 months (per EHR review and patient report)
Exclusion
- \<18 years old
- Unable to speak Spanish or English
- HIV or HCV positive
- Currently enrolled in another HIV or HCV research study
- Has tested for HIV or HCV in the past 12 months
Key Trial Info
Start Date :
December 4 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2026
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT05968573
Start Date
December 4 2023
End Date
August 1 2026
Last Update
July 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Icahn School of Medicine at Mount Sinai
New York, New York, United States, 10128